SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

uniQure N.V. – IPO: ‘F-1MEF’ on 2/4/14

On:  Tuesday, 2/4/14, at 8:49pm ET   ·   Effective:  2/4/14   ·   Accession #:  1104659-14-6469   ·   File #s:  333-193158, 333-193757

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/04/14  uniQure N.V.                      F-1MEF      2/04/14    3:176K                                   Merrill Corp-MD/FA

Initial Public Offering (IPO):  Registration of Additional Securities   —   Form F-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-1MEF      Registration of Additional Securities               HTML     68K 
 2: EX-5.1      Opinion re: Legality                                HTML     49K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML      8K 


F-1MEF   —   Registration of Additional Securities


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

As filed with the Securities and Exchange Commission on February 4, 2014

Registration No. 333-        

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM F-1

 

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

UNIQURE B.V.*

(Exact Name of Registrant as Specified in Its Charter)

 

N/A
(Translation of Registrant’s Name into English)

 

The Netherlands

 

2834

 

Not applicable

(State or Other Jurisdiction of
Incorporation or Organization)

 

(Primary Standard Industrial
Classification Code Number)

 

(I.R.S. Employer
Identification Number)

 

Jörn Aldag, Chief Executive Officer
Meibergdreef 61
Amsterdam 1105 BA, the Netherlands; Tel: +31 20 566 7394
(Address, Including ZIP Code, and Telephone Number,
Including Area Code, of Registrant’s Principal Executive Offices)

 


 

Philip Astley-Sparke, President U.S. Operations
uniQure, Inc.
113 Hartwell Avenue
Lexington, MA 02421
Tel: +31 20 566 7394
(Name, Address, Including ZIP Code, and Telephone Number,
Including Area Code, of Agent for Service)

 


 

Copies to:

David E. Redlick, Esq.
Timothy J. Corbett, Esq.
WilmerHale LLP
10 Noble Street
London EC2V 7QJ
United Kingdom
+44 20 7645 2400

 

Eric W. Blanchard, Esq.
Brian K. Rosenzweig, Esq.
Covington & Burling LLP
The New York Times Building
620 Eighth Avenue
New York, New York 10018
+1 212 841 1000

 

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.

 

If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.  o

 

If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  x 333-193158

 

If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

 

CALCULATION OF REGISTRATION FEE

 

 

 

 

 

 

 

 

 

 

CLASS OF SECURITIES TO BE REGISTERED

 

AMOUNT
TO BE
REGISTERED(1)

 

PROPOSED
MAXIMUM
OFFERING PRICE
PER ORDINARY 
SHARE(2)

 

PROPOSED
MAXIMUM
AGGREGATE 
OFFERING
PRICE(1)(2)

 

AMOUNT OF
REGISTRATION
FEE

 

Ordinary shares, par value €0.05 per share

 

920,000

 

$

17.00

 

15,640,000

 

$

2,015

 

(1)                                  Represents only the additional number of ordinary shares being registered and includes 120,000 ordinary shares that may be purchased by the underwriters pursuant to their option to purchase additional shares.  Does not include the ordinary shares that the Registrant previously registered on the Registration Statement on Form F-1 (File No. 333-193158).

(2)                                  Based on the public offering price.

 

THIS REGISTRATION STATEMENT SHALL BECOME EFFECTIVE UPON FILING WITH THE SECURITIES AND EXCHANGE COMMISSION IN ACCORDANCE WITH RULE 462(b) UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

 


 

* We intend to convert the legal form of our company under Dutch law from a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) to a public company with limited liability (naamloze vennootschap) and to change our name from uniQure B.V. to uniQure N.V. prior to the consummation of this offering.

 


 

 

 



 

EXPLANATORY NOTE AND INCORPORATION BY REFERENCE

 

This Registration Statement is being filed pursuant to Rule 462(b) (“Rule 462(b)”) and General Instruction V of Form F-1, both promulgated under the Securities Act of 1933, as amended. Pursuant to Rule 462(b), the contents of the Registration Statement on Form F-1 (File No. 333-193158) of uniQure B.V. (the “Registrant”), including the exhibits thereto, which was declared effective by the Securities and Exchange Commission on February 4, 2014, are incorporated by reference into this Registration Statement.

 

2



 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 16. Exhibits and Financial Statement Schedules.

 

All exhibits filed with or incorporated by reference in Registration Statement No. 333-193158 are incorporated by reference herein, and shall be deemed to be a part of this Registration Statement, except for the following, which are filed herewith.

 

Exhibit
Number

 

Description

 

 

 

5.1

 

Opinion of Rutgers Posch Visée Endedijk N.V.

 

 

 

23.1

 

Consent of PricewaterhouseCoopers Accountants N.V.

 

 

 

23.2

 

Consent of Rutgers Posch Visée Endedijk N.V. (included in Exhibit 5.1)

 

 

 

24.1

 

Powers of Attorney (included on the signature page to the Registration Statement on Form F-1 (File No. 333-193158), as amended, initially filed with the Securities and Exchange Commission on January 2, 2014 and incorporated by reference herein.)

 

 

 

24.2

 

Power of Attorney (incorporated by reference to Exhibit 24.2 of Amendment No 3. to the Registration Statement on Form F-1 (File No. 333-193158), filed with the Securities and Exchange Commission on January 31, 2014.)

 

3



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, on February 4, 2014.

 

 

UNIQURE B.V.

 

 

 

 

By:

/s/ PIERS MORGAN

 

 

 

 

Name:

Piers Morgan

 

Title:

Chief Financial Officer and Managing Director

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities held on the dates indicated.

 

SIGNATURES

 

TITLE

 

DATE

 

 

 

 

 

/s/ *

 

 

 

 

 

 

Chief Executive Officer

 

February 4, 2014

Jörn Aldag

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ PIERS MORGAN

 

Chief Financial Officer

 

February 4, 2014

Piers Morgan

 

(Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

 

 

 

 

 

/s/ *

 

Chairman

 

February 4, 2014

Ferdinand Verdonck

 

 

 

 

 

 

 

 

 

/s/ *

 

Non-Executive Director

 

February 4, 2014

Sander Slootweg

 

 

 

 

 

 

 

 

 

/s/ *

 

Non-Executive Director

 

February 4, 2014

Sander van Deventer

 

 

 

 

 

 

 

 

 

/s/ *

 

Non-Executive Director

 

February 4, 2014

Joseph M. Feczko

 

 

 

 

 

 

 

 

 

/s/ *

 

Non-Executive Director

 

February 4, 2014

François Meyer

 

 

 

 

 

 

 

 

 

/s/ *

 

Non-Executive Director

 

February 4, 2014

David Schaffer

 

 

 

 

 

 

 

 

 

/s/ *

 

Non-Executive Director

 

February 4, 2014

Paula Soteropoulos

 

 

 

 

 

*By:

/s/ PIERS MORGAN

 

Name: Piers Morgan

 

Title: Attorney-in-Fact

 

 

 

UNIQURE INC.

 

Authorized Representative in the United States

 

 

 

By:

/s/ PHILIP ASTLEY-SPARKE

 

Name: Philip Astley-Sparke

 

February 4, 2014

 

 

4



 

EXHIBITS

 

Exhibit
Number

 

Description

 

 

 

5.1

 

Opinion of Rutgers Posch Visée Endedijk N.V.

 

 

 

23.1

 

Consent of PricewaterhouseCoopers Accountants N.V.

 

 

 

23.2

 

Consent of Rutgers Posch Visée Endedijk N.V. (included in Exhibit 5.1)

 

 

 

24.1

 

Powers of Attorney (included on the signature page to the Registration Statement on Form F-1 (File No. 333-193158), as amended, initially filed with the Securities and Exchange Commission on January 2, 2014 and incorporated by reference herein.)

 

 

 

24.2

 

Power of Attorney (incorporated by reference to Exhibit 24.2 to Amendment No 3. to the Registration Statement on Form F-1 (File No. 333-193158), filed with the Securities and Exchange Commission on January 31, 2014.)

 

5



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘F-1MEF’ Filing    Date    Other Filings
Filed on / Effective on:2/4/14
1/31/148-A12B,  F-1/A
1/2/14F-1
 List all Filings
Top
Filing Submission 0001104659-14-006469   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 10:22:12.1am ET